DMAC vs WH · $157.4M cap vs P/E 20, rev $1.43B
DiaMedica Therapeutics Inc (DMAC) versus Wyndham Hotels & Resorts Inc (WH) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Wyndham Hotels & Resorts Inc (WH) is a lodging company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported WH revenue for 2025-12-31 was $1.43B. Net income was $193.0M. Revenue was up 1.5% from 2024-12-31 to 2025-12-31. WH currently screens at market cap $6.51B and trailing P/E 20.1.
DMAC currently screens at market cap $157.4M. WH currently screens at market cap $6.51B and trailing P/E 20.1.
Not investment advice. Open the DMAC and WH stock pages for the full models.
Not investment advice.